Consumer Goods » Food, Beverages & Tobacco | Rock Creek Pharmaceuticals Inc.

Rock Creek Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
10,188.00
23,121.00
3,881.00
395.00
493.00
Total Accounts Receivable
69.00
33.00
84.00
-
62.00
Inventories
2,740.00
4,989.00
3,473.00
-
-
Other Current Assets
737.00
1,140.00
1,575.00
7,406.00
488.00
Total Current Assets
13,734.00
29,283.00
9,013.00
7,801.00
1,043.00
Net Property, Plant & Equipment
2,347.00
1,338.00
399.00
207.00
170.00
Total Investments and Advances
368.00
481.00
482.00
482.00
17,777.00
Long-Term Note Receivable
50.00
18.00
517.00
-
-
Intangible Assets
578.00
541.00
472.00
402.00
55.00
Other Assets
-
263.00
69.00
25.00
502.00
Total Assets
17,077.00
31,924.00
10,952.00
8,917.00
19,547.00
ST Debt & Current Portion LT Debt
2,519.00
7.00
-
-
12,350.00
Accounts Payable
1,849.00
2,405.00
2,082.00
-
-
Other Current Liabilities
788.00
4,528.00
1,891.00
19,402.00
9,843.00
Total Current Liabilities
5,156.00
6,940.00
3,973.00
19,402.00
22,193.00
Long-Term Debt
2,530.00
-
-
350.00
8,000.00
Total Liabilities
7,686.00
6,940.00
3,973.00
19,752.00
30,193.00
Common Equity (Total)
9,391.00
24,984.00
6,979.00
10,835.00
10,646.00
Total Shareholders' Equity
9,391.00
24,984.00
6,979.00
10,835.00
10,646.00
Total Equity
9,391.00
24,984.00
6,979.00
10,835.00
10,646.00
Liabilities & Shareholders' Equity
17,077.00
31,924.00
10,952.00
8,917.00
19,547.00

About Rock Creek Pharmaceuticals

View Profile
Address
2040 Whitfield Avenue
Sarasota Florida 34243
United States
Employees -
Website -
Updated 07/08/2019
Rock Creek Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for chronic inflammatory disease, neurologic disorders, and behavioral health utilizing its proprietary compounds. It focuses on pharmaceutical development activities centered primarily on anatabine citrate as a lead drug candidate. The company was founded by Jonnie R.